haematology
Blood cancers

Relapsed/refractory multiple myeloma: why what you do next matters

Sponsored by Amgen Australia Pty Ltd

Addressing Amgen One’s Multiple Myeloma stream, Professor Keith Stewart from the Mayo Clinic in Phoenix Arizona didn’t mince words or dance around the point. Similar to his Harvard Medical School counterpart Professor Noopur Raje, Prof. Stewart was quick to acknowledge the limitations in Australia and emphasised the importance of fighting for funding of the latest ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic